Posted by Michael Wonder on 11 Feb 2017
Cancer drugs may be delayed after Brexit, say experts
10 February 2017 - Patients in the UK could face delays getting new drugs if Britain withdraws from the EU's medicines regulator, ministers have been warned.
Former UK regulator Sir Alasdair Breckenridge said new cancer drugs could be among those affected.
Health Secretary Jeremy Hunt said he did not expect the UK to remain within the EMA.
The Department for Health said Brexit offered new opportunities to bring timely access to new drugs.
